Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori Eradication
NCT07757919Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 4 trial of minocycline in Helicobacter pylori infection, sponsored by Qilu Hospital of Shandong University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
minocycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07757919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757919.